<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
		>

<channel>
	<title>Pulmonary Fibrosis News Forums | Jim Fletcher | Activity</title>
	<link>https://pulmonaryfibrosisnews.com/forums/members/jollyj/activity/</link>
	<atom:link href="https://pulmonaryfibrosisnews.com/forums/members/jollyj/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Jim Fletcher.</description>
	<lastBuildDate>Thu, 23 Apr 2026 13:45:40 -0500</lastBuildDate>
	<generator>https://buddypress.org/?v=2.20.0</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
		
								<item>
				<guid isPermaLink="false">a90d5da1c576a46036af20dd022e2202</guid>
				<title>Jim Fletcher replied to the discussion Starting Esbriet in the forum Esbriet (Pirfenidone)</title>
				<link>https://pulmonaryfibrosisnews.com/forums/forums/topic/starting-esbriet/#post-32169</link>
				<pubDate>Sun, 22 May 2022 20:03:27 -0500</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://pulmonaryfibrosisnews.com/forums/forums/topic/starting-esbriet/page/8/#post-32169"><span class="bb-reply-lable">Reply to</span> Starting Esbriet</a></p> <div class="bb-content-inr-wrap"><p>Thank you for your feedback. I hope the best for you. Still will be doing more research to the side effects and decide if they out weigh the benefit. </p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">4ad35f6e8aabb4926d15dacfdd716520</guid>
				<title>Jim Fletcher replied to the discussion Starting Esbriet in the forum Esbriet (Pirfenidone)</title>
				<link>https://pulmonaryfibrosisnews.com/forums/forums/topic/starting-esbriet/#post-32168</link>
				<pubDate>Sun, 22 May 2022 19:51:28 -0500</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://pulmonaryfibrosisnews.com/forums/forums/topic/starting-esbriet/page/8/#post-32168"><span class="bb-reply-lable">Reply to</span> Starting Esbriet</a></p> <div class="bb-content-inr-wrap"><p>Thanks for your feedback. I have a few weeks to decide whether to take the drug. I will be looking for to more feedback from more Esbriet users. </p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">6fdf2e6e00b3a41f472eef568e1e6c9c</guid>
				<title>Jim Fletcher replied to the discussion Starting Esbriet in the forum Esbriet (Pirfenidone)</title>
				<link>https://pulmonaryfibrosisnews.com/forums/forums/topic/starting-esbriet/#post-32164</link>
				<pubDate>Sun, 22 May 2022 11:58:28 -0500</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://pulmonaryfibrosisnews.com/forums/forums/topic/starting-esbriet/page/8/#post-32164"><span class="bb-reply-lable">Reply to</span> Starting Esbriet</a></p> <div class="bb-content-inr-wrap"><p>Hello<br />
I am a healthy 65 year old male having been just diagnosed with IPF in February of 2022. Just had second visit with pulmonologist and he wants to begin the drug Esbriet. After reading about the side effects of this drug, I am concerned how my quality of life will change and if it is worth it. From what I read there are only 48000&hellip;<span class="activity-read-more" id="activity-read-more-33532"><a href="https://pulmonaryfibrosisnews.com/forums/forums/topic/starting-esbriet/#post-32164" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">353a0f2e3602e13486b0aba27ccb3071</guid>
				<title>Jim Fletcher became a registered member</title>
				<link>https://pulmonaryfibrosisnews.com/forums/activity/p/33529/</link>
				<pubDate>Sat, 21 May 2022 19:23:16 -0500</pubDate>

				
									<slash:comments>1</slash:comments>
				
							</item>
		
	</channel>
</rss>
		